Literature DB >> 35261454

The Gaisbock syndrome after COVID-19 pneumonia.

Abbie Evans1, Busara Songtanin1, Kenneth Nugent1.   

Abstract

In 1905, Felix Gaisbock, MD, described a syndrome in patients with hypertension, elevated hematocrit levels, plethoric appearances, and no splenomegaly. He postulated this relative erythrocytosis was due to stress. In this case report, a 40-year-old Caucasian man with obesity was admitted with recurrent deep vein thrombosis and increasing oxygen requirements 2 weeks after hospitalization with COVID-19 pneumonia. This patient had a 10-year history of untreated hypertension and erythrocytosis. He had a ruddy appearance, a normal erythropoietin level, and a negative JAK2 V617 mutation. In this case, Gaisbock syndrome was suspected.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  Erythrocytosis; Gaisbock syndrome; hypertension

Year:  2022        PMID: 35261454      PMCID: PMC8865286          DOI: 10.1080/08998280.2021.2022370

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  7 in total

1.  Life-threatening thrombotic complications of relative polycythaemia.

Authors:  M Biswas; P K Prakash; M Cossburn; K Myers; F Hanna
Journal:  J Intern Med       Date:  2003-04       Impact factor: 8.989

2.  BENIGN POLYCYTHEMIA: GAISBOECK'S SYNDROME.

Authors:  R P RUSSELL; C L CONLEY
Journal:  Arch Intern Med       Date:  1964-12

3.  Erythrocytosis in the general population: clinical characteristics and association with clonal hematopoiesis.

Authors:  Hanneke J C M Wouters; René Mulder; Isabelle A van Zeventer; Jan Jacob Schuringa; Melanie M van der Klauw; Pim van der Harst; Arjan Diepstra; André B Mulder; Gerwin Huls
Journal:  Blood Adv       Date:  2020-12-22

Review 4.  Investigation and management of erythrocytosis.

Authors:  Siraj Mithoowani; Marissa Laureano; Mark A Crowther; Christopher M Hillis
Journal:  CMAJ       Date:  2020-08-10       Impact factor: 8.262

5.  Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up.

Authors:  D R Gagnon; T J Zhang; F N Brand; W B Kannel
Journal:  Am Heart J       Date:  1994-03       Impact factor: 4.749

6.  Gaisböck's syndrome: its hematologic, biochemical and hormonal parameters.

Authors:  M Stefanini; J V Urbas; J E Urbas
Journal:  Angiology       Date:  1978-07       Impact factor: 3.619

7.  Hematocrit increase by mental stress in hypertensive patients.

Authors:  Y Kitahara; K Imataka; H Nakaoka; M Ishibashi; T Yamaji; J Fujii
Journal:  Jpn Heart J       Date:  1988-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.